Charles J. Fisher Jr - Feb 10, 2022 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Role
Chief Executive Officer, Director
Signature
/s/ James B. Frakes, Attorney-in-Fact
Stock symbol
AEMD
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/11/2022, 12:54 PM
Previous filing
Jun 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEMD Employee Stock Option (Right to Buy) Award $0 +193K $0.00 193K Feb 10, 2022 Common Stock 193K $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest and become exercisable on February 10, 2023, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.